Cover
Cover - shares | 3 Months Ended | |
Mar. 31, 2023 | Apr. 21, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2023 | |
Document Transition Report | false | |
Entity File Number | 1-16191 | |
Entity Registrant Name | TENNANT CO | |
Entity Incorporation, State or Country Code | MN | |
Entity Tax Identification Number | 41-0572550 | |
Entity Address, Address Line One | 10400 Clean Street | |
Entity Address, City or Town | Eden Prairie | |
Entity Address, State or Province | MN | |
Entity Address, Postal Zip Code | 55344 | |
City Area Code | 763 | |
Local Phone Number | 540-1200 | |
Title of 12(b) Security | Common Stock, par value $0.375 per share | |
Trading Symbol | TNC | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 18,510,153 | |
Entity Central Index Key | 0000097134 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false |
CONSOLIDATED STATEMENTS OF INCO
CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Net sales | $ 305.8 | $ 258.1 |
Cost of sales | 180.3 | 159.2 |
Gross profit | 125.5 | 98.9 |
Selling and administrative expense | 81.7 | 76.6 |
Research and development expense | 7.9 | 7.7 |
Operating income | 35.9 | 14.6 |
Interest expense, net | (3.7) | (0.3) |
Net foreign currency transaction (loss) gain | (0.1) | 0.6 |
Other expense, net | (0.1) | (0.2) |
Income before income taxes | 32 | 14.7 |
Income tax expense | 7.7 | 4.4 |
Net income | $ 24.3 | $ 10.3 |
Net income per share | ||
Net income per share, Basic (in dollars per share) | $ 1.32 | $ 0.56 |
Net income per share, Diluted (in dollars per share) | $ 1.30 | $ 0.55 |
Weighted average shares outstanding | ||
Weighted average shares outstanding, Basic (in shares) | 18,449,430 | 18,463,419 |
Weighted average shares outstanding, Diluted (in shares) | 18,682,268 | 18,799,732 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 24.3 | $ 10.3 |
Other comprehensive income (loss): | ||
Foreign currency translation adjustments (net of related tax benefit (expense) of $0.1 and $(0.4), respectively) | 5.3 | (3.8) |
Derivative financial instruments (net of related tax benefit of $0.2 and $0.1, respectively) | (0.6) | (0.2) |
Total other comprehensive income (loss), net of tax | 4.7 | (4) |
Comprehensive income | $ 29 | $ 6.3 |
CONSOLIDATED STATEMENTS OF CO_2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (Parentheticals) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Foreign currency translation adjustments tax benefit (expense) | $ 0.1 | $ (0.4) |
Cash flow hedge tax benefit | $ 0.2 | $ 0.1 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
ASSETS | ||
Cash, cash equivalents, and restricted cash | $ 91.4 | $ 77.4 |
Receivables, less allowances of $7.8 and $6.1, respectively | 254.3 | 251.5 |
Inventories | 203.6 | 206.6 |
Prepaid and other current assets | 33.1 | 39.8 |
Total current assets | 582.4 | 575.3 |
Property, plant and equipment, less accumulated depreciation of $287.3 and $279.3, respectively | 182.8 | 179.9 |
Operating lease assets | 33.4 | 31.8 |
Goodwill | 185 | 182 |
Intangible assets, net | 73.2 | 76.4 |
Other assets | 43.9 | 39.7 |
Total assets | 1,100.7 | 1,085.1 |
LIABILITIES AND EQUITY | ||
Current portion of long-term debt | 5.3 | 5.2 |
Accounts payable | 117.6 | 126.1 |
Employee compensation and benefits | 44.9 | 44 |
Other current liabilities | 89 | 86.3 |
Total current liabilities | 256.8 | 261.6 |
Long-term debt | 293.8 | 295.1 |
Long-term operating lease liabilities | 18.3 | 17.1 |
Employee benefits | 13.3 | 13.2 |
Deferred income taxes | 10.5 | 11.5 |
Other liabilities | 14.8 | 14.5 |
Total long-term liabilities | 350.7 | 351.4 |
Total liabilities | 607.5 | 613 |
Commitments and contingencies (Note 11) | ||
Common stock, $0.375 par value; 60,000,000 shares authorized; 18,541,033 and 18,521,485 shares issued and outstanding, respectively | 7 | 7 |
Additional paid-in capital | 53 | 56 |
Retained earnings | 477.4 | 458 |
Accumulated other comprehensive loss | (45.5) | (50.2) |
Total Tennant Company shareholders' equity | 491.9 | 470.8 |
Noncontrolling interest | 1.3 | 1.3 |
Total equity | 493.2 | 472.1 |
Total liabilities and total equity | $ 1,100.7 | $ 1,085.1 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Allowance for credit loss | $ 7.8 | $ 6.1 |
Accumulated depreciation | $ 287.3 | $ 279.3 |
Common stock, par value (in dollars per share) | $ 0.375 | $ 0.375 |
Common stock, shares authorized (in shares) | 60,000,000 | 60,000,000 |
Common stock, shares issued (in shares) | 18,541,033 | 18,521,485 |
Common stock, shares outstanding (in shares) | 18,541,033 | 18,521,485 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
OPERATING ACTIVITIES | ||
Net income | $ 24.3 | $ 10.3 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
Depreciation expense | 8.3 | 8.2 |
Amortization expense | 3.9 | 4.5 |
Deferred income tax benefit | (2) | (1.3) |
Share-based compensation expense | 1.2 | 1.8 |
Bad debt and returns expense | 1 | 0.4 |
Other, net | 0.2 | 0.2 |
Changes in operating assets and liabilities: | ||
Receivables | (2.5) | 10.1 |
Inventories | (1.5) | (29) |
Accounts payable | (6.6) | 2 |
Employee compensation and benefits | 0.5 | (12.6) |
Other assets and liabilities | 4.3 | (4.7) |
Net cash provided by (used in) operating activities | 31.1 | (10.1) |
INVESTING ACTIVITIES | ||
Purchases of property, plant and equipment | (6.8) | (5) |
Investment in leased assets | (0.2) | (3.7) |
Cash received from leased assets | 0.2 | 0.1 |
Net cash used in investing activities | (6.8) | (8.6) |
FINANCING ACTIVITIES | ||
Proceeds from borrowings | 20 | 15 |
Repayments of borrowings | (21.4) | (0.9) |
Change in finance lease obligations | 0.2 | 0 |
Proceeds (repurchases) from exercise of stock options, net of employee tax withholdings obligations | 0.8 | (1.2) |
Repurchases of common stock | (5) | 0 |
Dividends paid | (4.9) | (4.6) |
Net cash (used in) provided by financing activities | (10.3) | 8.3 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | (2.8) |
Net increase (decrease) in cash, cash equivalents and restricted cash | 14 | (13.2) |
Cash, cash equivalents and restricted cash at beginning of period | 77.4 | 123.6 |
Cash, cash equivalents and restricted cash at end of period | 91.4 | 110.4 |
SUPPLEMENTAL CASH FLOW INFORMATION | ||
Cash paid for income taxes | 0.8 | 1.3 |
Cash paid for interest | 4.5 | 1 |
Cash paid for amounts included in the measurement of lease liabilities: | ||
Operating cash flows from operating leases | 4.6 | 4.9 |
Financing cash flows from financing leases | 0 | 0.1 |
Lease assets obtained in exchange for new operating lease liabilities | 4.6 | 2.8 |
Supplemental non-cash investing and financing activities: | ||
Capital expenditures in accounts payable | $ 1.5 | $ 1.6 |
CONSOLIDATED STATEMENTS OF EQUI
CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($) | Total | Tennant Company Shareholders' Equity | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Noncontrolling Interest |
Beginning balance (in shares) at Dec. 31, 2021 | 18,535,116 | ||||||
Beginning balance at Dec. 31, 2021 | $ 435,100,000 | $ 433,800,000 | $ 7,000,000 | $ 54,100,000 | $ 410,600,000 | $ (37,900,000) | $ 1,300,000 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 10,300,000 | 10,300,000 | 10,300,000 | ||||
Other comprehensive income (loss) | (4,000,000) | (4,000,000) | (4,000,000) | ||||
Issue stock for directors, employee benefit and stock plans, net of related tax withholdings and repurchases (in shares) | 44,700 | ||||||
Issue stock for directors, employee benefit and stock plans, net of related tax withholdings and repurchases | (1,300,000) | (1,300,000) | $ 0 | (1,300,000) | |||
Share-based compensation | 1,800,000 | 1,800,000 | 1,800,000 | ||||
Dividends paid per common share | (4,600,000) | (4,600,000) | (4,600,000) | ||||
Ending balance (in shares) at Mar. 31, 2022 | 18,579,816 | ||||||
Ending balance at Mar. 31, 2022 | $ 437,300,000 | 436,000,000 | $ 7,000,000 | 54,600,000 | 416,300,000 | (41,900,000) | 1,300,000 |
Beginning balance (in shares) at Dec. 31, 2022 | 18,521,485 | 18,521,485 | |||||
Beginning balance at Dec. 31, 2022 | $ 472,100,000 | 470,800,000 | $ 7,000,000 | 56,000,000 | 458,000,000 | (50,200,000) | 1,300,000 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 24,300,000 | 24,300,000 | 24,300,000 | ||||
Other comprehensive income (loss) | 4,700,000 | 4,700,000 | 4,700,000 | ||||
Issue stock for directors, employee benefit and stock plans, net of related tax withholdings and repurchases (in shares) | 93,073 | ||||||
Issue stock for directors, employee benefit and stock plans, net of related tax withholdings and repurchases | 800,000 | 800,000 | 800,000 | ||||
Share-based compensation | 1,200,000 | 1,200,000 | 1,200,000 | ||||
Repurchases of common stock | (5,000,000) | (5,000,000) | $ (73,525) | (5,000,000) | |||
Dividends paid per common share | $ (4,900,000) | (4,900,000) | (4,900,000) | ||||
Ending balance (in shares) at Mar. 31, 2023 | 18,541,033 | 18,541,033 | |||||
Ending balance at Mar. 31, 2023 | $ 493,200,000 | $ 491,900,000 | $ 7,000,000 | $ 53,000,000 | $ 477,400,000 | $ (45,500,000) | $ 1,300,000 |
CONSOLIDATED STATEMENTS OF EQ_2
CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) (Parentheticals) - $ / shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Stockholders' Equity [Abstract] | ||
Shares withheld for taxes (in shares) | 18,468 | 24,025 |
Dividends paid per common share (in dollars per share) | $ 0.265 | $ 0.25 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Tennant Company ("the Company", "we", "us", or "our") is a world leader in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Our products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools and universities, hospitals and clinics, and more. Customers include contract cleaners to whom organizations outsource facilities maintenance as well as businesses that perform facilities maintenance themselves. The Company reaches these customers through the industry's largest direct sales and service organization and through a strong and well-supported network of authorized distributors worldwide. Basis of Presentation – The accompanying unaudited consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission (“SEC”) requirements for interim reporting. In our opinion, the consolidated financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary for the fair presentation of our financial position and results of operations. These statements should be read in conjunction with the consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2022. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. |
Newly Adopted Accounting Pronou
Newly Adopted Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Newly Adopted Accounting Pronouncements | Newly Adopted Accounting Pronouncements Reference Rate Reform In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU No. 2020-04, Reference Rate Reform (Topic 848), and in December 2022 subsequently issued ASU 2022-06, to temporarily ease the potential burden in accounting for reference rate reform. The standard provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications, hedging relationships, and other transactions affected by the reference rate reform, which affects the London Inter-bank Offered Rate ("LIBOR"), if certain criteria are met. The guidance was effective upon issuance and can generally be applied through December 31, 2024. There has been no material impact to our financial condition, results of operations, or cash flows from reference rate reform as of March 31, 2023. See Note 7 for information on the replacement of LIBOR with the Secured Overnight Financing Rate ("SOFR") in our Credit Agreements (defined below). |
Revenue
Revenue | 3 Months Ended |
Mar. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Disaggregation of Revenue The following tables illustrate the disaggregation of revenue by geographic area, groups of similar products and services and sales channels: Net sales by geographic area Three Months Ended 2023 2022 Americas $ 204.4 $ 160.3 Europe, Middle East and Africa 82.1 78.7 Asia Pacific 19.4 19.1 Total $ 305.8 $ 258.1 Net sales are attributed to each geographic area based on the end-user country and are net of intercompany sales. Net sales by groups of similar products and services Three Months Ended 2023 2022 Equipment $ 186.4 $ 158.1 Parts and consumables 73.4 60.6 Service and other 46.0 39.4 Total $ 305.8 $ 258.1 Net sales by sales channel Three Months Ended 2023 2022 Sales direct to consumer $ 205.1 $ 163.8 Sales to distributors 100.7 94.3 Total $ 305.8 $ 258.1 Contract Liabilities Sales Returns The right of return may exist explicitly or implicitly with our customers. When the right of return exists, we adjust the transaction price for the estimated effect of returns. We estimate the expected returns using the expected value method by assessing historical sales levels and the timing and magnitude of historical sales return levels as a percent of sales and projecting this experience into the future. Sales Incentives Our sales contracts may contain various customer incentives, such as volume-based rebates or other promotions. We reduce the transaction price for certain customer programs and incentive offerings that represent variable consideration. Sales incentives given to our customers are recorded using the most likely amount approach for estimating the amount of consideration to which the Company will be entitled. We forecast the most likely amount of the incentive to be paid at the time of sale, update this forecast quarterly, and adjust the transaction price accordingly to reflect the new amount of incentives expected to be earned by the customer. A majority of our customer incentives are settled within one year. We record our accruals for volume-based rebates and other promotions in other current liabilities on our consolidated balance sheets. The change in our sales incentive accrual balance was as follows: Three Months Ended 2023 2022 Beginning balance $ 20.0 $ 19.9 Additions to sales incentive accrual 6.6 4.4 Contract payments (11.3) (12.8) Foreign currency fluctuations 0.1 (0.2) Ending balance $ 15.4 $ 11.3 Deferred Revenue We sell separately priced prepaid contracts to our customers where we receive payment at the inception of the contract and defer recognition of the consideration received because we have to satisfy future performance obligations. Our deferred revenue balance is primarily attributed to prepaid maintenance contracts on our machines ranging from 12 months to 60 months. In circumstances where prepaid contracts are bundled with machines, we use an observable price to determine stand-alone selling price for separate performance obligations. The change in the deferred revenue balance was as follows: Three Months Ended 2023 2022 Beginning balance $ 9.3 $ 11.2 Increase in deferred revenue representing our obligation to satisfy future performance obligations 5.5 7.4 Decrease in deferred revenue for amounts recognized in net sales for satisfied performance obligations (4.7) (6.5) Foreign currency fluctuations 0.1 0.1 Ending balance $ 10.2 $ 12.2 At March 31, 2023, $7.9 million and $2.3 million of deferred revenue was reported in other current liabilities and other liabilities, respectively, on our consolidated balance sheets. Of these amounts, we expect to recognize the following approximate amounts in net sales in the following periods: Remaining 2023 $ 7.0 2024 1.8 2025 0.9 2026 0.3 2027 0.1 Thereafter 0.1 Total $ 10.2 At December 31, 2022, $6.6 million and $2.7 million of deferred revenue was reported in other current liabilities and other liabilities, respectively, on our consolidated balance sheets. |
Management Actions
Management Actions | 3 Months Ended |
Mar. 31, 2023 | |
Restructuring and Related Activities [Abstract] | |
Management Actions | Management Actions Restructuring Actions During the three months ended March 31, 2022, we incurred restructuring expenses as part of our ongoing global reorganization efforts. The pre-tax charge of $0.8 million consisted of severance-related costs included in selling and administrative expense in the consolidated statements of income. The charge in 2022 primarily impacted the Americas operating segments. Our restructuring actions represent the continued execution of a multi-year enterprise strategy to drive increased productivity throughout our operations. A reconciliation of the beginning and ending liability balances for severance-related costs is as follows: Three Months Ended 2023 2022 Beginning balance $ 1.7 $ 4.9 New charges — 0.8 Cash payments (0.5) (0.7) Foreign currency fluctuations — (0.1) Adjustments to accrual — (0.6) Ending balance $ 1.2 $ 4.3 |
Inventories
Inventories | 3 Months Ended |
Mar. 31, 2023 | |
Inventory Disclosure [Abstract] | |
Inventories | Inventories Inventories are valued at the lower of cost or net realizable value and consisted of the following: March 31, December 31, Inventories carried at LIFO: Finished goods (a) $ 78.8 $ 85.0 Raw materials and work-in-process 43.2 46.4 Excess of FIFO over LIFO cost (b) (46.8) (49.7) Total LIFO inventories $ 75.2 $ 81.7 Inventories carried at FIFO: Finished goods (a) $ 85.2 $ 68.9 Raw materials and work-in-process 43.2 56.0 Total FIFO inventories $ 128.4 $ 124.9 Total inventories $ 203.6 $ 206.6 (a) Finished goods include machines, parts and consumables and component parts that are used in our products. (b) The difference between replacement cost and the stated LIFO inventory value is not materially different from the reserve for the LIFO valuation method. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 3 Months Ended |
Mar. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets The changes in the carrying amount of goodwill for the three months ended March 31, 2023 were as follows: Goodwill Accumulated Impairment Losses Total Balance as of December 31, 2022 $ 218.8 $ (36.8) $ 182.0 Foreign currency fluctuations 4.5 (1.5) 3.0 Balance as of March 31, 2023 $ 223.3 $ (38.3) $ 185.0 The balances of acquired intangible assets, excluding goodwill, were as follows: Customer Lists Trade Names Technology Total Balance as of March 31, 2023 Original cost $ 148.5 $ 28.9 $ 16.1 $ 193.5 Accumulated amortization (91.5) (16.8) (12.0) (120.3) Carrying value $ 57.0 $ 12.1 $ 4.1 $ 73.2 Weighted average original life (in years) 15 11 11 Balance as of December 31, 2022 Original cost $ 146.6 $ 28.6 $ 15.9 $ 191.1 Accumulated amortization (87.5) (15.9) (11.3) (114.7) Carrying value $ 59.1 $ 12.7 $ 4.6 $ 76.4 Weighted average original life (in years) 15 11 11 Amortization expense on intangible assets for the three months ended March 31, 2023 and 2022 was $3.9 million and $4.5 million, respectively. Estimated aggregate amortization expense based on the current carrying value of amortizable intangible assets for each of the five succeeding years and thereafter is as follows: Remaining 2023 $ 11.3 2024 12.9 2025 11.5 2026 10.3 2027 7.6 Thereafter 19.6 Total $ 73.2 |
Debt
Debt | 3 Months Ended |
Mar. 31, 2023 | |
Debt Disclosure [Abstract] | |
Debt | Debt 2021 Credit Agreement On April 5, 2021, we and certain of our foreign subsidiaries entered into an Amended and Restated Credit Agreement (the “2021 Credit Agreement”) with JPMorgan Chase Bank, N.A. as administrative agent. The 2021 Credit Agreement provides us and certain of our foreign subsidiaries access to a senior secured credit facility until April 3, 2026, consisting of a term loan facility in an amount up to $100.0 million and a revolving facility in an amount up to $450.0 million with an option to expand the credit facility by up to $275.0 million, with the consent of the lenders willing to provide additional borrowings in the form of increases to their revolving facility commitment or funding of incremental term loans. Borrowings may be denominated in U.S. dollars or certain other currencies. On November 10, 2022, we further amended the 2021 Credit Agreement (the "Amendment") to update the benchmark provisions to replace LIBOR with Term SOFR (as defined in the Amendment) as the reference rate for purposes of calculating interest under the 2021 Credit Agreement. Pursuant to the Amendment, borrowings denominated in U.S. dollars bear interest at a rate per annum equal to (a) the Term SOFR Rate (as defined in the Amendment) plus a credit spread adjustment of 0.10% per annum, but in any case, not less than 0%, plus an additional spread of 1.10% to 1.70%, depending on the Company’s leverage ratio, or (b) the Alternate Base Rate (as defined in the Amendment), which is the greatest of (i) the prime rate, (ii) the federal funds rate plus 0.50% and (iii) the adjusted Term SOFR Rate for a one month period, but in any case, not less than 1.0%, plus, in any such case, 1.0%, plus an additional spread of 0.10% to 0.70%, depending on the Company’s leverage ratio. All other material terms included in the 2021 Credit Agreement remain unchanged as a result of the Amendment. In connection with the 2021 Credit Agreement, we reaffirmed our security interest in favor of the lenders in substantially all our personal property and pledged the stock of our domestic subsidiaries and 65% of the stock of our first-tier foreign subsidiaries. The obligations under the 2021 Credit Agreement are also guaranteed by certain of our first-tier domestic subsidiaries, and those subsidiaries also provided a security interest in their similar personal property. The 2021 Credit Agreement restricts the payment of dividends or repurchasing of stock requiring that, after giving effect to such payments, no default exists or would result from such payment. Additionally, cash dividends are restricted to $7.5 million per quarter and approved levels of other restricted payments range from $60.0 million to unlimited based on our net leverage ratio (not taking into account any acquisition holiday) after giving effect to such payment. The 2021 Credit Agreement contains customary representations, warranties and covenants, including but not limited to covenants restricting our ability to incur indebtedness and liens and to merge or consolidate with another entity. Further, the 2021 Credit Agreement contains the following covenants: • A covenant requiring us to maintain an indebtedness to EBITDA ratio, determined as of the end of each of our fiscal quarters, of no greater than 3.50 to 1.00, with certain alternative requirements for permitted acquisitions greater than $50.0 million; • A covenant requiring us to maintain an EBITDA to interest expense ratio for a period of four consecutive fiscal quarters as of the end of each quarter of no less than 3.00 to 1.00; and • A covenant restricting us from paying dividends or repurchasing stock if, after giving effect to such payments and assuming no default exists or would result from such payment, our leverage ratio is greater than 2.50 to 1.00, in such case limiting such payments to $60.0 million during any fiscal year. Debt Outstanding Debt outstanding consisted of the following: March 31, 2023 December 31, 2022 Credit facility borrowings: Revolving credit facility borrowings $ 205.0 $ 205.0 Term loan facility borrowings 93.7 95.0 Secured borrowings 0.1 0.2 Finance lease liabilities 0.3 0.1 Total debt 299.1 300.3 Less: current portion of long-term debt (a) (5.3) (5.2) Long-term debt $ 293.8 $ 295.1 (a) As of March 31, 2023, the Company is required to repay $5.0 million in outstanding credit facility borrowings and $0.3 million of finance lease liabilities over the next 12 months. As of March 31, 2023, we had outstanding borrowings of $205.0 million and $93.7 million under our revolving facility and term loan facility, respectively. We had letters of credit and bank guarantees outstanding in the amount of $2.7 million, leaving approximately $242.3 million of unused borrowing capacity on our revolving facility. Commitment fees on unused lines of credit for the three months ended March 31, 2023 were $0.2 million. The overall weighted average cost of debt was approximately 5.8% and net of related cross-currency swap instruments was approximately 4.9%. Further details regarding the cross-currency swap instrument are discussed in Note 9. |
Warranty
Warranty | 3 Months Ended |
Mar. 31, 2023 | |
Guarantees [Abstract] | |
Warranty | Warranty We record a liability for warranty claims at the time of sale. The amount of the liability is based on the trend in the historical ratio of claims to sales, the historical length of time between the sale and resulting warranty claim, new product introductions and other factors. Warranty terms on machines generally range from one The changes in warranty reserves were as follows: Three Months Ended 2023 2022 Beginning balance $ 10.9 $ 10.4 Additions charged to expense 3.4 1.7 Foreign currency fluctuations 0.1 — Claims paid (3.1) (1.9) Ending balance $ 11.3 $ 10.2 |
Derivatives
Derivatives | 3 Months Ended |
Mar. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivatives | Derivatives Hedge Accounting and Hedging Programs We recognize all derivative instruments as either assets or liabilities in our consolidated balance sheets and measure them at fair value. Gains and losses resulting from changes in fair value are accounted for depending on the use of the derivative and whether it is designated and qualifies for hedge accounting. We evaluate hedge effectiveness on our hedges that are designated and qualify for hedge accounting at the inception of the hedge prospectively, as well as retrospectively, and record any ineffective portion of the hedging instruments along with the time value of purchased contracts in the same line item of the income statement as the item being hedged on our consolidated statements of income. Our hedging policy establishes maximum limits for each counterparty to mitigate any concentration of risk. Balance Sheet Hedges We hedge our net recognized foreign currency denominated assets and liabilities with foreign exchange forward contracts to reduce the risk that the value of these assets and liabilities will be adversely affected by changes in exchange rates. These contracts hedge assets and liabilities that are denominated in foreign currencies and are carried at fair value as either assets or liabilities on the consolidated balance sheets with changes in the fair value recorded to net foreign currency transaction (loss) gain in our consolidated statements of income. These contracts do not subject us to material balance sheet risk due to exchange rate movements because gains and losses on these derivatives are intended to offset gains and losses on the assets and liabilities being hedged. At March 31, 2023 and December 31, 2022, the notional amounts of foreign currency forward exchange contracts outstanding not designated as hedging instruments were $100.1 million and $83.7 million, respectively. Cash Flow Hedges We manage our floating rate debt exposure using interest rate swaps. Fixed rate swaps are used to reduce our risk of the possibility of increased interest costs. We entered into an aggregate $120 million notional amount of interest rate swaps effective December 1, 2022 that exchange a variable rate of interest for a fixed rate of interest of 4.076%. These interest rate swaps are designated as cash flow hedges. These swaps are scheduled to mature on December 1, 2026. Fair Value Hedges On April 5, 2022, we entered into Euro to U.S. dollar foreign exchange cross-currency swaps associated with an intercompany loan from a wholly owned European subsidiary. We enter into these foreign exchange cross-currency swaps to hedge the foreign currency risk associated with this intercompany loan, and accordingly, they are not speculative in nature. These cross-currency swaps are designated as fair value hedges. As of March 31, 2023 and December 31, 2022, these cross-currency swaps included €84.2 million and €84.8 million of total notional value, respectively. As of March 31, 2023, the aggregated scheduled interest payments over the course of the loan and related swaps amounted to €9.2 million. The scheduled maturity and principal payment of the loan and related swaps of €75.0 million are due in April 2027. Net Investment Hedges On April 5, 2022, we entered into Euro to U.S. dollar foreign exchange cross-currency swaps to hedge our exposure to adverse foreign currency exchange rate movements between Tennant Company and a wholly owned European subsidiary. We enter into these fixed-to-fixed cross-currency swap agreements to protect a designated monetary amount of the Company’s net investment in its Euro functional currency subsidiary against the risk of changes in the Euro to U.S. dollar foreign exchange rate. These cross-currency swaps are designated as net investment hedges. As of December 31, 2022 and March 31, 2023, the cross-currency swaps included €75.0 million of total notional values. These swaps are scheduled to mature in April 2027. The fair value of derivative instruments on our consolidated balance sheets was as follows: Derivative Assets Derivative Liabilities Balance Sheet Location March 31, 2023 December 31, 2022 Balance Sheet Location March 31, 2023 December 31, 2022 Derivatives designated as cash flow hedges: Interest rate swaps Other current assets $ 0.7 $ 0.8 Other current liabilities $ — $ — Interest rate swaps Other assets — — Other liabilities 3.0 1.8 Derivatives designated as fair value hedges: Cross-currency swaps Other current assets 1.4 1.4 Other current liabilities — — Cross-currency swaps Other assets 0.4 0.8 Other liabilities — — Derivatives designated as net investment hedges: Cross-currency swaps Other current assets 1.2 1.2 Other current liabilities — — Cross-currency swaps Other assets — 0.5 Other liabilities — — Derivatives not designated as hedging instruments: Foreign currency forward contracts Other current assets $ — $ 0.1 Other current liabilities $ 1.1 $ 0.3 As of March 31, 2023, we anticipate reclassifying $1.9 million of gains from accumulated other comprehensive loss to net income during the next 12 months. The following tables includes the amounts in the consolidated statements of income in which the effects of derivatives designated as hedging instruments are recorded: Three Months Ended 2023 2022 Total Amount of Gain on Hedging Total Amount of Gain on Hedging Derivatives designated as cash flow hedges: Interest expense, net $ (3.7) $ 0.1 $ (0.3) $ 0.7 Net foreign currency transaction (loss) gain (0.1) — 0.6 4.5 Derivatives designated as fair value hedges: Interest expense, net (3.7) 1.2 (0.3) — Net foreign currency transaction (loss) gain (0.1) 1.2 0.6 — Derivatives designated as net investment hedges: Interest expense, net $ (3.7) $ 0.9 $ (0.3) $ — The effect of derivative instruments designated as hedges and derivative instruments not designated as hedges in our consolidated statements of income was as follows: Three Months Ended 2023 2022 Derivatives designated as cash flow hedges: Net (loss) gain recognized in other comprehensive income (loss), net of tax (a) $ (0.9) $ 3.8 Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to interest expense, net 0.1 0.5 Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to net foreign currency transaction gain — 3.5 Derivatives designated as fair value hedges: Net gain recognized in other comprehensive income (loss), net of tax (a) 0.7 — Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to interest expense, net 0.3 — Derivatives designated as net investment hedges: Net loss recognized in other comprehensive income (loss), net of tax (a) (0.1) — Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to interest expense, net 0.2 — Derivatives not designated as hedging instruments: Net gain recognized in income (b) $ 0.8 $ 1.6 (a) Net change in the fair value of the effective portion classified in other comprehensive income (loss). (b) Classified in net foreign currency transaction (loss) gain. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements Estimates of fair value for financial assets and financial liabilities are based on the framework established in the accounting guidance for fair value measurements. The framework defines fair value, provides guidance for measuring fair value and requires certain disclosures. The framework discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow) and the cost approach (cost to replace the service capacity of an asset or replacement cost). The framework utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: • Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. • Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. • Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions. Our population of assets and liabilities subject to fair value measurements at March 31, 2023 was as follows: Fair Level 1 Level 2 Level 3 Assets: Cross-currency swaps $ 3.0 $ — $ 3.0 $ — Interest rate swaps 0.7 — 0.7 — Total assets 3.7 — 3.7 — Liabilities: Foreign currency forward exchange contracts 1.1 — 1.1 — Interest rate swaps 3.0 — 3.0 — Total liabilities $ 4.1 $ — $ 4.1 $ — Our population of assets and liabilities subject to fair value measurements at December 31, 2022 was as follows: Fair Level 1 Level 2 Level 3 Assets: Foreign currency forward exchange contracts $ 0.1 $ — $ 0.1 $ — Cross-currency swaps 3.9 — 3.9 — Interest rate swaps 0.8 — 0.8 — Total assets 4.8 — 4.8 — Liabilities: Foreign currency forward exchange contracts 0.3 — 0.3 — Interest rate swaps 1.8 — 1.8 — Total liabilities $ 2.1 $ — $ 2.1 $ — Our foreign currency forward exchange contracts and cross-currency swaps are valued using observable Level 2 market expectations at the measurement date and standard valuation techniques to convert future amounts to a single present value amount. Further details regarding our derivative instruments are discussed in Note 9. The carrying amounts reported in the consolidated balance sheets for cash and cash equivalents, restricted cash, accounts receivable, other current assets, accounts payable and other current liabilities approximate fair value due to their short-term nature. The fair value and carrying value of total debt, including current portion, was $297.8 million and $299.1 million, respectively, as of March 31, 2023. The fair value and carrying value of total debt, including current portion, was $301.8 million and $300.3 million, respectively, as of December 31, 2022. The fair value was calculated based on the borrowing rates currently available to us for bank loans with similar terms and remaining maturities, which is a Level 2 in the fair value hierarchy. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and ContingenciesIn the ordinary course of business, we may become liable with respect to pending and threatened litigation, tax, environmental and other matters. While the ultimate results of current claims, investigations and lawsuits involving us are unknown at this time, we do not expect that these matters will have a material adverse effect on our consolidated financial position or results of operations. Legal costs associated with such matters are expensed as incurred. |
Shareholders' Equity
Shareholders' Equity | 3 Months Ended |
Mar. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Shareholders' Equity | Shareholders' Equity Accumulated Other Comprehensive Loss The changes in components of accumulated other comprehensive loss, net of tax, are as follows: Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 Foreign Currency Pension and Post- Derivative Financial Instruments Total Foreign Currency Pension and Post- Derivative Financial Instruments Total Beginning balance $ (53.9) $ 2.7 $ 1.0 $ (50.2) $ (36.0) $ (2.1) $ 0.2 $ (37.9) Other comprehensive income (loss) before reclassifications 5.5 — (0.2) 5.3 (3.8) — 3.8 — Amounts reclassified from accumulated other comprehensive loss (0.2) — (0.4) (0.6) — — (4.0) (4.0) Net current period other comprehensive income (loss) 5.3 — (0.6) 4.7 (3.8) — (0.2) (4.0) Ending balance $ (48.6) $ 2.7 $ 0.4 $ (45.5) $ (39.8) $ (2.1) $ — $ (41.9) |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes We and our subsidiaries are subject to U.S. federal income tax as well as income tax of numerous state and foreign jurisdictions. We are generally no longer subject to U.S. federal tax examinations for taxable years before 2018. The number of years which remain open for audit for U.S. state or foreign tax purposes varies by jurisdiction but generally ranges from three We recognize potential accrued interest and penalties related to unrecognized tax benefits in income tax expense. In addition to the liability of $4.1 million for unrecognized tax benefits as of March 31, 2023, there was approximately $0.6 million for accrued interest and penalties. The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate as of March 31, 2023 was $3.9 million. To the extent interest and penalties are not assessed with respect to uncertain tax positions, amounts accrued will be revised and reflected as an adjustment of the income tax expense. |
Share-Based Compensation
Share-Based Compensation | 3 Months Ended |
Mar. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Share-Based Compensation | Share-Based CompensationOur share-based compensation plans are described in Note 18 of our annual report on Form 10-K for the year ended December 31, 2022. During the three months ended March 31, 2023 and 2022, we recognized total share-based compensation expense of $1.2 million and $1.8 million, respectively. The total excess tax benefit recognized for share-based compensation arrangements during the three months ended March 31, 2023 and 2022 was less than $0.1 million and $0.3 million, respectively. |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
Mar. 31, 2023 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share The computations of basic and diluted earnings per share were as follows: Three Months Ended 2023 2022 Numerator: Net income $ 24.3 $ 10.3 Denominator: Basic - weighted average shares outstanding 18,449,430 18,463,419 Effect of dilutive securities: 232,838 336,313 Diluted - weighted average shares outstanding 18,682,268 18,799,732 Basic earnings per share $ 1.32 $ 0.56 Diluted earnings per share $ 1.30 $ 0.55 Excluded from the dilutive securities shown above were options to purchase and shares to be paid out under share-based compensation plans of 393,242 and 191,587 shares of common stock during the three months ended March 31, 2023 and 2022, respectively. These exclusions were made if the exercise prices of the options are greater than the average market price of our common stock for the period, if the number of shares we can repurchase under the treasury stock method exceeds the weighted average shares outstanding in the options or if we have a net loss, as these effects would be anti-dilutive. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation – The accompanying unaudited consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission (“SEC”) requirements for interim reporting. In our opinion, the consolidated financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary for the fair presentation of our financial position and results of operations. These statements should be read in conjunction with the consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2022. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. |
Newly Adopted Accounting Pronouncements | Newly Adopted Accounting Pronouncements Reference Rate Reform In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU No. 2020-04, Reference Rate Reform (Topic 848), and in December 2022 subsequently issued ASU 2022-06, to temporarily ease the potential burden in accounting for reference rate reform. The standard provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications, hedging relationships, and other transactions affected by the reference rate reform, which affects the London Inter-bank Offered Rate ("LIBOR"), if certain criteria are met. The guidance was effective upon issuance and can generally be applied through December 31, 2024. There has been no material impact to our financial condition, results of operations, or cash flows from reference rate reform as of March 31, 2023. See Note 7 for information on the replacement of LIBOR with the Secured Overnight Financing Rate ("SOFR") in our Credit Agreements (defined below). |
Revenue (Tables)
Revenue (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Disaggregation of Revenue | The following tables illustrate the disaggregation of revenue by geographic area, groups of similar products and services and sales channels: Net sales by geographic area Three Months Ended 2023 2022 Americas $ 204.4 $ 160.3 Europe, Middle East and Africa 82.1 78.7 Asia Pacific 19.4 19.1 Total $ 305.8 $ 258.1 Net sales are attributed to each geographic area based on the end-user country and are net of intercompany sales. Net sales by groups of similar products and services Three Months Ended 2023 2022 Equipment $ 186.4 $ 158.1 Parts and consumables 73.4 60.6 Service and other 46.0 39.4 Total $ 305.8 $ 258.1 Net sales by sales channel Three Months Ended 2023 2022 Sales direct to consumer $ 205.1 $ 163.8 Sales to distributors 100.7 94.3 Total $ 305.8 $ 258.1 |
Schedule of Change in Sales Incentive Accrual Balance and Deferred Revenue Balance | The change in our sales incentive accrual balance was as follows: Three Months Ended 2023 2022 Beginning balance $ 20.0 $ 19.9 Additions to sales incentive accrual 6.6 4.4 Contract payments (11.3) (12.8) Foreign currency fluctuations 0.1 (0.2) Ending balance $ 15.4 $ 11.3 The change in the deferred revenue balance was as follows: Three Months Ended 2023 2022 Beginning balance $ 9.3 $ 11.2 Increase in deferred revenue representing our obligation to satisfy future performance obligations 5.5 7.4 Decrease in deferred revenue for amounts recognized in net sales for satisfied performance obligations (4.7) (6.5) Foreign currency fluctuations 0.1 0.1 Ending balance $ 10.2 $ 12.2 |
Schedule of Recognition of Net Sales in Future Periods | Of these amounts, we expect to recognize the following approximate amounts in net sales in the following periods: Remaining 2023 $ 7.0 2024 1.8 2025 0.9 2026 0.3 2027 0.1 Thereafter 0.1 Total $ 10.2 |
Management Actions (Tables)
Management Actions (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Restructuring and Related Activities [Abstract] | |
Schedule of Reconciliation of Liability Balance of Severance and Related Costs | A reconciliation of the beginning and ending liability balances for severance-related costs is as follows: Three Months Ended 2023 2022 Beginning balance $ 1.7 $ 4.9 New charges — 0.8 Cash payments (0.5) (0.7) Foreign currency fluctuations — (0.1) Adjustments to accrual — (0.6) Ending balance $ 1.2 $ 4.3 |
Inventories (Tables)
Inventories (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventories | Inventories are valued at the lower of cost or net realizable value and consisted of the following: March 31, December 31, Inventories carried at LIFO: Finished goods (a) $ 78.8 $ 85.0 Raw materials and work-in-process 43.2 46.4 Excess of FIFO over LIFO cost (b) (46.8) (49.7) Total LIFO inventories $ 75.2 $ 81.7 Inventories carried at FIFO: Finished goods (a) $ 85.2 $ 68.9 Raw materials and work-in-process 43.2 56.0 Total FIFO inventories $ 128.4 $ 124.9 Total inventories $ 203.6 $ 206.6 (a) Finished goods include machines, parts and consumables and component parts that are used in our products. (b) The difference between replacement cost and the stated LIFO inventory value is not materially different from the reserve for the LIFO valuation method. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Changes in the Carrying Amount of Goodwill | The changes in the carrying amount of goodwill for the three months ended March 31, 2023 were as follows: Goodwill Accumulated Impairment Losses Total Balance as of December 31, 2022 $ 218.8 $ (36.8) $ 182.0 Foreign currency fluctuations 4.5 (1.5) 3.0 Balance as of March 31, 2023 $ 223.3 $ (38.3) $ 185.0 |
Schedule of Acquired Intangible Assets | The balances of acquired intangible assets, excluding goodwill, were as follows: Customer Lists Trade Names Technology Total Balance as of March 31, 2023 Original cost $ 148.5 $ 28.9 $ 16.1 $ 193.5 Accumulated amortization (91.5) (16.8) (12.0) (120.3) Carrying value $ 57.0 $ 12.1 $ 4.1 $ 73.2 Weighted average original life (in years) 15 11 11 Balance as of December 31, 2022 Original cost $ 146.6 $ 28.6 $ 15.9 $ 191.1 Accumulated amortization (87.5) (15.9) (11.3) (114.7) Carrying value $ 59.1 $ 12.7 $ 4.6 $ 76.4 Weighted average original life (in years) 15 11 11 |
Schedule of Estimated Aggregate Amortization Expense | Estimated aggregate amortization expense based on the current carrying value of amortizable intangible assets for each of the five succeeding years and thereafter is as follows: Remaining 2023 $ 11.3 2024 12.9 2025 11.5 2026 10.3 2027 7.6 Thereafter 19.6 Total $ 73.2 |
Debt (Tables)
Debt (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Debt Outstanding | Debt outstanding consisted of the following: March 31, 2023 December 31, 2022 Credit facility borrowings: Revolving credit facility borrowings $ 205.0 $ 205.0 Term loan facility borrowings 93.7 95.0 Secured borrowings 0.1 0.2 Finance lease liabilities 0.3 0.1 Total debt 299.1 300.3 Less: current portion of long-term debt (a) (5.3) (5.2) Long-term debt $ 293.8 $ 295.1 (a) As of March 31, 2023, the Company is required to repay $5.0 million in outstanding credit facility borrowings and $0.3 million of finance lease liabilities over the next 12 months. |
Warranty (Tables)
Warranty (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Guarantees [Abstract] | |
Schedule of Changes in Warranty Reserves | The changes in warranty reserves were as follows: Three Months Ended 2023 2022 Beginning balance $ 10.9 $ 10.4 Additions charged to expense 3.4 1.7 Foreign currency fluctuations 0.1 — Claims paid (3.1) (1.9) Ending balance $ 11.3 $ 10.2 |
Derivatives (Tables)
Derivatives (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Fair Value of Derivative Instruments | The fair value of derivative instruments on our consolidated balance sheets was as follows: Derivative Assets Derivative Liabilities Balance Sheet Location March 31, 2023 December 31, 2022 Balance Sheet Location March 31, 2023 December 31, 2022 Derivatives designated as cash flow hedges: Interest rate swaps Other current assets $ 0.7 $ 0.8 Other current liabilities $ — $ — Interest rate swaps Other assets — — Other liabilities 3.0 1.8 Derivatives designated as fair value hedges: Cross-currency swaps Other current assets 1.4 1.4 Other current liabilities — — Cross-currency swaps Other assets 0.4 0.8 Other liabilities — — Derivatives designated as net investment hedges: Cross-currency swaps Other current assets 1.2 1.2 Other current liabilities — — Cross-currency swaps Other assets — 0.5 Other liabilities — — Derivatives not designated as hedging instruments: Foreign currency forward contracts Other current assets $ — $ 0.1 Other current liabilities $ 1.1 $ 0.3 |
Schedule of Effects of Derivatives Designated as Hedging Instruments | The following tables includes the amounts in the consolidated statements of income in which the effects of derivatives designated as hedging instruments are recorded: Three Months Ended 2023 2022 Total Amount of Gain on Hedging Total Amount of Gain on Hedging Derivatives designated as cash flow hedges: Interest expense, net $ (3.7) $ 0.1 $ (0.3) $ 0.7 Net foreign currency transaction (loss) gain (0.1) — 0.6 4.5 Derivatives designated as fair value hedges: Interest expense, net (3.7) 1.2 (0.3) — Net foreign currency transaction (loss) gain (0.1) 1.2 0.6 — Derivatives designated as net investment hedges: Interest expense, net $ (3.7) $ 0.9 $ (0.3) $ — The effect of derivative instruments designated as hedges and derivative instruments not designated as hedges in our consolidated statements of income was as follows: Three Months Ended 2023 2022 Derivatives designated as cash flow hedges: Net (loss) gain recognized in other comprehensive income (loss), net of tax (a) $ (0.9) $ 3.8 Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to interest expense, net 0.1 0.5 Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to net foreign currency transaction gain — 3.5 Derivatives designated as fair value hedges: Net gain recognized in other comprehensive income (loss), net of tax (a) 0.7 — Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to interest expense, net 0.3 — Derivatives designated as net investment hedges: Net loss recognized in other comprehensive income (loss), net of tax (a) (0.1) — Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to interest expense, net 0.2 — Derivatives not designated as hedging instruments: Net gain recognized in income (b) $ 0.8 $ 1.6 (a) Net change in the fair value of the effective portion classified in other comprehensive income (loss). (b) Classified in net foreign currency transaction (loss) gain. |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets and Liabilities Subject to Fair Value Measurements | Our population of assets and liabilities subject to fair value measurements at March 31, 2023 was as follows: Fair Level 1 Level 2 Level 3 Assets: Cross-currency swaps $ 3.0 $ — $ 3.0 $ — Interest rate swaps 0.7 — 0.7 — Total assets 3.7 — 3.7 — Liabilities: Foreign currency forward exchange contracts 1.1 — 1.1 — Interest rate swaps 3.0 — 3.0 — Total liabilities $ 4.1 $ — $ 4.1 $ — Our population of assets and liabilities subject to fair value measurements at December 31, 2022 was as follows: Fair Level 1 Level 2 Level 3 Assets: Foreign currency forward exchange contracts $ 0.1 $ — $ 0.1 $ — Cross-currency swaps 3.9 — 3.9 — Interest rate swaps 0.8 — 0.8 — Total assets 4.8 — 4.8 — Liabilities: Foreign currency forward exchange contracts 0.3 — 0.3 — Interest rate swaps 1.8 — 1.8 — Total liabilities $ 2.1 $ — $ 2.1 $ — |
Shareholders' Equity (Tables)
Shareholders' Equity (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Accumulated Other Comprehensive Loss, Net of Tax | The changes in components of accumulated other comprehensive loss, net of tax, are as follows: Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 Foreign Currency Pension and Post- Derivative Financial Instruments Total Foreign Currency Pension and Post- Derivative Financial Instruments Total Beginning balance $ (53.9) $ 2.7 $ 1.0 $ (50.2) $ (36.0) $ (2.1) $ 0.2 $ (37.9) Other comprehensive income (loss) before reclassifications 5.5 — (0.2) 5.3 (3.8) — 3.8 — Amounts reclassified from accumulated other comprehensive loss (0.2) — (0.4) (0.6) — — (4.0) (4.0) Net current period other comprehensive income (loss) 5.3 — (0.6) 4.7 (3.8) — (0.2) (4.0) Ending balance $ (48.6) $ 2.7 $ 0.4 $ (45.5) $ (39.8) $ (2.1) $ — $ (41.9) |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Computations of Basic and Diluted Earnings per Share | The computations of basic and diluted earnings per share were as follows: Three Months Ended 2023 2022 Numerator: Net income $ 24.3 $ 10.3 Denominator: Basic - weighted average shares outstanding 18,449,430 18,463,419 Effect of dilutive securities: 232,838 336,313 Diluted - weighted average shares outstanding 18,682,268 18,799,732 Basic earnings per share $ 1.32 $ 0.56 Diluted earnings per share $ 1.30 $ 0.55 |
Revenue - Disaggregation of Rev
Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Disaggregation of Revenue [Line Items] | ||
Net sales | $ 305.8 | $ 258.1 |
Sales direct to consumer | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 205.1 | 163.8 |
Sales to distributors | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 100.7 | 94.3 |
Equipment | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 186.4 | 158.1 |
Parts and consumables | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 73.4 | 60.6 |
Service and other | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 46 | 39.4 |
Americas | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 204.4 | 160.3 |
Europe, Middle East and Africa | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 82.1 | 78.7 |
Asia Pacific | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | $ 19.4 | $ 19.1 |
Revenue - Narrative (Details)
Revenue - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | |
Other current liabilities | Maintenance | ||
Disaggregation of Revenue [Line Items] | ||
Deferred revenue other current liabilities | $ 7.9 | $ 6.6 |
Other liabilities | Maintenance | ||
Disaggregation of Revenue [Line Items] | ||
Deferred revenue other liabilities | $ 2.3 | $ 2.7 |
Short-Term Contract with Customer | ||
Disaggregation of Revenue [Line Items] | ||
Standard prepaid maintenance contract time period (months) | 12 months | |
Long-Term Contract with Customer | ||
Disaggregation of Revenue [Line Items] | ||
Standard prepaid maintenance contract time period (months) | 60 months |
Revenue - Contract Liabilities
Revenue - Contract Liabilities (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Sales Incentives | ||
Movement in Deferred Sales Inducements [Roll Forward] | ||
Beginning balance | $ 20 | $ 19.9 |
Additions to sales incentive accrual | 6.6 | 4.4 |
Contract payments | (11.3) | (12.8) |
Foreign currency fluctuations | 0.1 | (0.2) |
Ending balance | 15.4 | 11.3 |
Movement in Deferred Revenue [Roll Forward] | ||
Foreign currency fluctuations | 0.1 | (0.2) |
Maintenance | ||
Movement in Deferred Sales Inducements [Roll Forward] | ||
Foreign currency fluctuations | 0.1 | 0.1 |
Movement in Deferred Revenue [Roll Forward] | ||
Beginning balance | 9.3 | 11.2 |
Increase in deferred revenue representing our obligation to satisfy future performance obligations | 5.5 | 7.4 |
Decrease in deferred revenue for amounts recognized in net sales for satisfied performance obligations | (4.7) | (6.5) |
Foreign currency fluctuations | 0.1 | 0.1 |
Ending balance | $ 10.2 | $ 12.2 |
Revenue - Remaining Performance
Revenue - Remaining Performance Obligation (Details) $ in Millions | Mar. 31, 2023 USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Total remaining performance obligation | $ 10.2 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Total remaining performance obligation | 7 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Total remaining performance obligation | 1.8 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Total remaining performance obligation | 0.9 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Total remaining performance obligation | 0.3 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Total remaining performance obligation | 0.1 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Total remaining performance obligation | $ 0.1 |
Revenue - Remaining Performan_2
Revenue - Remaining Performance Obligation (Details) | Mar. 31, 2023 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | |
Disaggregation of Revenue [Line Items] | |
Total remaining performance obligation | 9 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | |
Disaggregation of Revenue [Line Items] | |
Total remaining performance obligation | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |
Disaggregation of Revenue [Line Items] | |
Total remaining performance obligation | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | |
Disaggregation of Revenue [Line Items] | |
Total remaining performance obligation | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01 | |
Disaggregation of Revenue [Line Items] | |
Total remaining performance obligation | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01 | |
Disaggregation of Revenue [Line Items] | |
Total remaining performance obligation | 1 year |
Management Actions - Narrative
Management Actions - Narrative (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2022 USD ($) | |
Selling, General and Administrative Expenses | |
Restructuring Cost and Reserve [Line Items] | |
Severance costs | $ 0.8 |
Management Actions - Reconcilia
Management Actions - Reconciliation of Liability Balance of Severance and Related Costs (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Restructuring Reserve [Roll Forward] | ||
Beginning balance | $ 1.7 | $ 4.9 |
New charges | 0 | 0.8 |
Cash payments | (0.5) | (0.7) |
Foreign currency fluctuations | 0 | (0.1) |
Adjustments to accrual | 0 | (0.6) |
Ending balance | $ 1.2 | $ 4.3 |
Inventories - Inventories (Deta
Inventories - Inventories (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
Inventory [Line Items] | ||
Excess of FIFO over LIFO cost | $ (46.8) | $ (49.7) |
Total LIFO inventories | 75.2 | 81.7 |
Total FIFO inventories | 128.4 | 124.9 |
Total inventories | 203.6 | 206.6 |
Inventories carried at LIFO: | ||
Inventory [Line Items] | ||
Finished goods | 78.8 | 85 |
Raw materials and work-in-process | 43.2 | 46.4 |
Inventories carried at FIFO: | ||
Inventory [Line Items] | ||
Finished goods | 85.2 | 68.9 |
Raw materials and work-in-process | $ 43.2 | $ 56 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Changes in Carrying Amount of Goodwill (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Goodwill [Roll Forward] | |
Beginning balance | $ 218.8 |
Beginning balance, accumulated impairment losses | (36.8) |
Beginning balance, net | 182 |
Foreign currency fluctuations | 4.5 |
Foreign currency fluctuations, accumulated impairment losses | (1.5) |
Foreign currency fluctuations, net | 3 |
Ending balance | 223.3 |
Ending balance, accumulated impairment losses | (38.3) |
Ending balance, net | $ 185 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Balances of Acquired Intangible Assets, Excluding Goodwill (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Finite-Lived Intangible Assets [Line Items] | ||
Original cost | $ 193.5 | $ 191.1 |
Accumulated amortization | (120.3) | (114.7) |
Carrying value | 73.2 | 76.4 |
Customer Lists | ||
Finite-Lived Intangible Assets [Line Items] | ||
Original cost | 148.5 | 146.6 |
Accumulated amortization | (91.5) | (87.5) |
Carrying value | $ 57 | $ 59.1 |
Weighted average original life (in years) | 15 years | 15 years |
Trade Names | ||
Finite-Lived Intangible Assets [Line Items] | ||
Original cost | $ 28.9 | $ 28.6 |
Accumulated amortization | (16.8) | (15.9) |
Carrying value | $ 12.1 | $ 12.7 |
Weighted average original life (in years) | 11 years | 11 years |
Technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Original cost | $ 16.1 | $ 15.9 |
Accumulated amortization | (12) | (11.3) |
Carrying value | $ 4.1 | $ 4.6 |
Weighted average original life (in years) | 11 years | 11 years |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Amortization expense | $ 3.9 | $ 4.5 |
Goodwill and Intangible Asset_5
Goodwill and Intangible Assets - Estimated Aggregate Amortization Expense (Details) $ in Millions | Mar. 31, 2023 USD ($) |
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract] | |
Remaining 2023 | $ 11.3 |
2024 | 12.9 |
2025 | 11.5 |
2026 | 10.3 |
2027 | 7.6 |
Thereafter | 19.6 |
Total | $ 73.2 |
Debt - Narrative (Details)
Debt - Narrative (Details) | 3 Months Ended | |||
Nov. 10, 2022 | Apr. 05, 2021 USD ($) | Mar. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | |
Debt Instrument [Line Items] | ||||
Cross-currency swap instruments, net | 4.90% | |||
The 2021 Credit Agreement | ||||
Debt Instrument [Line Items] | ||||
Collateral, percentage of stock of first tier foreign subsidiaries | 65% | |||
Dividend payments | $ 7,500,000 | |||
EBITDA ratio, maximum | 3.50 | |||
Permitted acquisitions | $ 50,000,000 | |||
Maximum EBITDA to interest expense ratio | 300% | |||
Leverage ratio minimum | 2.50 | |||
Dividends payout | $ 60,000,000 | |||
Letters of credit outstanding | $ 2,700,000 | |||
Commitment fees on unused lines of credit | 200,000 | |||
The 2021 Credit Agreement | Secured Overnight Financing Rate | ||||
Debt Instrument [Line Items] | ||||
Basis spread on variable rate | 0.10% | |||
The 2021 Credit Agreement | SOFR on Eurocurrency Liabilities | ||||
Debt Instrument [Line Items] | ||||
Variable rate floor | 0% | |||
The 2021 Credit Agreement | Fed Funds Effective Rate Overnight Index Swap Rate | ||||
Debt Instrument [Line Items] | ||||
Basis spread on variable rate | 0.50% | |||
The 2021 Credit Agreement | Adjusted Secured Overnight Financing Rate | ||||
Debt Instrument [Line Items] | ||||
Variable rate floor | 1% | |||
The 2021 Credit Agreement | Minimum | ||||
Debt Instrument [Line Items] | ||||
Other restricted payments | 60,000,000 | |||
The 2021 Credit Agreement | Minimum | SOFR on Eurocurrency Liabilities | ||||
Debt Instrument [Line Items] | ||||
Basis spread on variable rate | 1.10% | |||
The 2021 Credit Agreement | Minimum | Adjusted Secured Overnight Financing Rate | ||||
Debt Instrument [Line Items] | ||||
Basis spread on variable rate | 0.10% | |||
The 2021 Credit Agreement | Maximum | SOFR on Eurocurrency Liabilities | ||||
Debt Instrument [Line Items] | ||||
Basis spread on variable rate | 1.70% | |||
The 2021 Credit Agreement | Maximum | Adjusted Secured Overnight Financing Rate | ||||
Debt Instrument [Line Items] | ||||
Basis spread on variable rate | 0.70% | |||
The 2021 Credit Agreement | Revolving credit facility borrowings | ||||
Debt Instrument [Line Items] | ||||
Revolving credit facility | 450,000,000 | |||
Credit facility | 275,000,000 | |||
Outstanding borrowings | 205,000,000 | $ 205,000,000 | ||
Unused borrowing capacity | 242,300,000 | |||
The 2021 Credit Agreement | Term loan facility borrowings | ||||
Debt Instrument [Line Items] | ||||
Outstanding principal amount | $ 100,000,000 | |||
Outstanding borrowings | $ 93,700,000 | $ 95,000,000 | ||
Debt Including Related Cross-currency Swap Instrument | ||||
Debt Instrument [Line Items] | ||||
Weighted average cost of debt | 5.80% |
Debt - Debt Outstanding (Detail
Debt - Debt Outstanding (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
Debt Instrument [Line Items] | ||
Finance lease liabilities | $ 0.3 | $ 0.1 |
Total debt | 299.1 | 300.3 |
Less: current portion of long-term debt | (5.3) | (5.2) |
Long-term debt | 293.8 | 295.1 |
Secured borrowings | ||
Debt Instrument [Line Items] | ||
Outstanding borrowings | 0.1 | 0.2 |
The 2021 Credit Agreement | ||
Debt Instrument [Line Items] | ||
Repayment of outstanding credit facility borrowings | 5 | |
Finance lease liabilities current | 0.3 | |
The 2021 Credit Agreement | Term loan facility borrowings | ||
Debt Instrument [Line Items] | ||
Outstanding borrowings | 93.7 | 95 |
The 2021 Credit Agreement | Revolving credit facility borrowings | ||
Debt Instrument [Line Items] | ||
Outstanding borrowings | $ 205 | $ 205 |
Warranty - Narrative (Details)
Warranty - Narrative (Details) | 3 Months Ended |
Mar. 31, 2023 | |
Maximum | |
Guarantor Obligations [Line Items] | |
Machine warranty, period (Year) | 4 years |
Minimum | |
Guarantor Obligations [Line Items] | |
Machine warranty, period (Year) | 1 year |
Warranty - Changes in Warranty
Warranty - Changes in Warranty Reserves (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Movement in Standard Product Warranty Accrual [Roll Forward] | ||
Beginning balance | $ 10.9 | $ 10.4 |
Additions charged to expense | 3.4 | 1.7 |
Foreign currency fluctuations | 0.1 | 0 |
Claims paid | (3.1) | (1.9) |
Ending balance | $ 11.3 | $ 10.2 |
Derivatives - Narrative (Detail
Derivatives - Narrative (Details) € in Millions, $ in Millions | 3 Months Ended | |||||
Mar. 31, 2023 USD ($) | Mar. 31, 2023 EUR (€) | Mar. 31, 2023 EUR (€) | Dec. 31, 2022 USD ($) | Dec. 31, 2022 EUR (€) | Dec. 01, 2022 USD ($) | |
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Cash flow hedge gain reclassified | $ | $ 1.9 | |||||
Foreign currency forward contracts | Derivatives not designated as hedging instruments: | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Derivative, notional amount | $ | $ 100.1 | $ 83.7 | ||||
Interest rate swaps | Designated as Hedging Instrument | Derivatives designated as cash flow hedges: | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Derivative, notional amount | $ | $ 120 | |||||
Derivative, Fixed Interest Rate | 4.076% | |||||
Cross-currency swaps | Designated as Hedging Instrument | Derivatives designated as fair value hedges: | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Derivative, notional amount | € 84.2 | € 84.8 | ||||
Debt instrument, periodic payment, interest | € 9.2 | |||||
Debt instrument, periodic payment, principal | € 75 | |||||
Cross-currency swaps | Designated as Hedging Instrument | Derivatives designated as net investment hedges: | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Derivative, notional amount | € 75 | € 75 |
Derivatives - Fair Value of Der
Derivatives - Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
Designated as Hedging Instrument | Interest rate swaps | Derivatives designated as cash flow hedges: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Assets | $ 0.7 | $ 0.8 |
Derivative Liabilities | 0 | 0 |
Derivative other asset, before offset | 0 | 0 |
Derivative other liability, asset offset | 3 | 1.8 |
Designated as Hedging Instrument | Cross-currency swaps | Derivatives designated as fair value hedges: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Assets | 1.4 | 1.4 |
Derivative Liabilities | 0 | 0 |
Derivative other asset, before offset | 0.4 | 0.8 |
Derivative other liability, asset offset | 0 | 0 |
Designated as Hedging Instrument | Cross-currency swaps | Derivatives designated as net investment hedges: | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Assets | 1.2 | 1.2 |
Derivative Liabilities | 0 | 0 |
Derivative other asset, before offset | 0 | 0.5 |
Derivative other liability, asset offset | 0 | 0 |
Derivatives not designated as hedging instruments: | Foreign currency forward contracts | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Assets | 0 | 0.1 |
Derivative Liabilities | $ 1.1 | $ 0.3 |
Derivatives - Effect of Derivat
Derivatives - Effect of Derivative Instruments on Consolidated Statements of Earnings (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Interest expense, net | $ (3.7) | $ (0.3) |
Net foreign currency transaction (loss) gain | (0.1) | 0.6 |
Net (loss) gain recognized in other comprehensive income (loss), net of tax | (0.6) | (0.2) |
Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to net foreign currency transaction gain | (0.1) | 0.6 |
Designated as Hedging Instrument | Derivatives designated as cash flow hedges: | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Interest expense, net | (3.7) | (0.3) |
Net foreign currency transaction (loss) gain | (0.1) | 0.6 |
Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to net foreign currency transaction gain | (0.1) | 0.6 |
Designated as Hedging Instrument | Derivatives designated as cash flow hedges: | Interest expense, net | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Amount of Gain on Hedging Activity | 0.1 | 0.7 |
Designated as Hedging Instrument | Derivatives designated as cash flow hedges: | Net foreign currency transaction (loss) gain | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Amount of Gain on Hedging Activity | 0 | 4.5 |
Designated as Hedging Instrument | Derivatives designated as fair value hedges: | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Interest expense, net | (3.7) | (0.3) |
Net foreign currency transaction (loss) gain | (0.1) | 0.6 |
Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to net foreign currency transaction gain | (0.1) | 0.6 |
Designated as Hedging Instrument | Derivatives designated as fair value hedges: | Interest expense, net | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Amount of Gain on Hedging Activity | 1.2 | 0 |
Designated as Hedging Instrument | Derivatives designated as fair value hedges: | Net foreign currency transaction (loss) gain | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Amount of Gain on Hedging Activity | 1.2 | 0 |
Designated as Hedging Instrument | Derivatives designated as net investment hedges: | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Interest expense, net | (3.7) | (0.3) |
Designated as Hedging Instrument | Derivatives designated as net investment hedges: | Interest expense, net | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Amount of Gain on Hedging Activity | 0.9 | 0 |
Designated as Hedging Instrument | Foreign Exchange Option | Derivatives designated as cash flow hedges: | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Net foreign currency transaction (loss) gain | 0 | 3.5 |
Net (loss) gain recognized in other comprehensive income (loss), net of tax | (0.9) | 3.8 |
Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to interest expense, net | 0.1 | 0.5 |
Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to net foreign currency transaction gain | 0 | 3.5 |
Designated as Hedging Instrument | Foreign Exchange Option | Derivatives designated as fair value hedges: | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Net (loss) gain recognized in other comprehensive income (loss), net of tax | 0.7 | 0 |
Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to interest expense, net | 0.3 | 0 |
Designated as Hedging Instrument | Foreign Exchange Option | Derivatives designated as net investment hedges: | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Net (loss) gain recognized in other comprehensive income (loss), net of tax | (0.1) | 0 |
Net gain reclassified from accumulated other comprehensive loss into income, net of tax, effective portion to interest expense, net | 0.2 | 0 |
Derivatives not designated as hedging instruments: | Foreign Exchange Option | ||
Foreign Currency Fair Value Hedge Derivative [Line Items] | ||
Net gain recognized in income | $ 0.8 | $ 1.6 |
Fair Value Measurements - Fair
Fair Value Measurements - Fair Value Measurements of Assets and Liabilities (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Total assets | $ 3.7 | $ 4.8 |
Total liabilities | 4.1 | 2.1 |
Level 1 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Total assets | 0 | 0 |
Total liabilities | 0 | 0 |
Level 2 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Total assets | 3.7 | 4.8 |
Total liabilities | 4.1 | 2.1 |
Level 3 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Total assets | 0 | 0 |
Total liabilities | 0 | 0 |
Foreign currency forward contracts | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Foreign currency forward exchange contracts | 0.1 | |
Foreign currency forward exchange contracts | 1.1 | 0.3 |
Foreign currency forward contracts | Level 1 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Foreign currency forward exchange contracts | 0 | |
Foreign currency forward exchange contracts | 0 | 0 |
Foreign currency forward contracts | Level 2 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Foreign currency forward exchange contracts | 0.1 | |
Foreign currency forward exchange contracts | 1.1 | 0.3 |
Foreign currency forward contracts | Level 3 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Foreign currency forward exchange contracts | 0 | |
Foreign currency forward exchange contracts | 0 | 0 |
Cross-currency swaps | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative asset | 3 | 3.9 |
Cross-currency swaps | Level 1 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative asset | 0 | 0 |
Cross-currency swaps | Level 2 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative asset | 3 | 3.9 |
Cross-currency swaps | Level 3 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative asset | 0 | 0 |
Interest rate swaps | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative asset | 0.7 | 0.8 |
Interest rate swaps | 3 | 1.8 |
Interest rate swaps | Level 1 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative asset | 0 | 0 |
Interest rate swaps | 0 | 0 |
Interest rate swaps | Level 2 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative asset | 0.7 | 0.8 |
Interest rate swaps | 3 | 1.8 |
Interest rate swaps | Level 3 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative asset | 0 | 0 |
Interest rate swaps | $ 0 | $ 0 |
Fair Value Measurements - Narra
Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
Fair Value Disclosures [Abstract] | ||
Fair value of total debt | $ 297.8 | $ 301.8 |
Carrying value of total debt | $ 299.1 | $ 300.3 |
Shareholders' Equity - Accumula
Shareholders' Equity - Accumulated Other Comprehensive Loss, Net of Tax (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | $ 472.1 | $ 435.1 |
Other comprehensive income (loss) before reclassifications | 5.3 | 0 |
Amounts reclassified from accumulated other comprehensive loss | (0.6) | (4) |
Total other comprehensive income (loss), net of tax | 4.7 | (4) |
Ending balance | 493.2 | 437.3 |
Total | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | (50.2) | (37.9) |
Ending balance | (45.5) | (41.9) |
Foreign Currency Translation Adjustments | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | (53.9) | (36) |
Other comprehensive income (loss) before reclassifications | 5.5 | (3.8) |
Amounts reclassified from accumulated other comprehensive loss | (0.2) | 0 |
Total other comprehensive income (loss), net of tax | 5.3 | (3.8) |
Ending balance | (48.6) | (39.8) |
Pension and Post- Retirement Medical Benefits | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | 2.7 | (2.1) |
Other comprehensive income (loss) before reclassifications | 0 | 0 |
Amounts reclassified from accumulated other comprehensive loss | 0 | 0 |
Total other comprehensive income (loss), net of tax | 0 | 0 |
Ending balance | 2.7 | (2.1) |
Derivative Financial Instruments | ||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | ||
Beginning balance | 1 | 0.2 |
Other comprehensive income (loss) before reclassifications | (0.2) | 3.8 |
Amounts reclassified from accumulated other comprehensive loss | (0.4) | (4) |
Total other comprehensive income (loss), net of tax | (0.6) | (0.2) |
Ending balance | $ 0.4 | $ 0 |
Income Taxes (Details)
Income Taxes (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Income Tax Contingency [Line Items] | |
Unrecognized tax benefits, ending balance | $ 4.1 |
Unrecognized tax benefits, income tax penalties and interest accrued, total | 0.6 |
Unrecognized tax benefits that would impact effective tax rate | $ 3.9 |
Minimum | |
Income Tax Contingency [Line Items] | |
Open tax year, term (year) | 3 years |
Maximum | |
Income Tax Contingency [Line Items] | |
Open tax year, term (year) | 5 years |
Share-Based Compensation (Detai
Share-Based Compensation (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | ||
Share-based payment arrangement, expense | $ 1.2 | $ 1.8 |
Share-based payment arrangement, expense, tax benefit | $ 0.1 | $ 0.3 |
Earnings Per Share - Computatio
Earnings Per Share - Computations of Basic and Diluted Earnings (Loss) Attributable to Tennant Company Per Share (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Numerator: | ||
Net income | $ 24.3 | $ 10.3 |
Denominator: | ||
Basic - weighted average shares outstanding (in shares) | 18,449,430 | 18,463,419 |
Effect of dilutive securities: | 232,838 | 336,313 |
Diluted - weighted average shares outstanding (in shares) | 18,682,268 | 18,799,732 |
Basic earnings per share (in dollars per share) | $ 1.32 | $ 0.56 |
Diluted earnings per share (in dollars per share) | $ 1.30 | $ 0.55 |
Earnings Per Share - Narrative
Earnings Per Share - Narrative (Details) - shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Earnings Per Share [Abstract] | ||
Antidilutive securities (in shares) | 393,242 | 191,587 |